Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

FDA Appoints Psychedelics Advocate as CDER Deputy Director Amid Leadership Changes

FDA Appoints Psychedelics Advocate as CDER Deputy Director Amid Leadership Changes

The U.S. Food and Drug Administration (FDA) has named Mike Davis, a physician with a background in psychedelic research, as the new deputy director of its Center for Drug Evaluation and Research (CDER). This appointment comes at a time of significant leadership transitions within the agency and growing interest in psychedelic therapies within the pharmaceutical industry.

NoahAI News6/26/2025
Nektar's Rezpeg Shows Promise in Phase IIb Eczema Trial, but Analysts Remain Cautious

Nektar's Rezpeg Shows Promise in Phase IIb Eczema Trial, but Analysts Remain Cautious

Nektar Therapeutics has reported positive results from its Phase IIb REZOLVE-AD trial for rezpegaldesleukin (rezpeg) in atopic dermatitis, sparking a significant surge in the company's stock price. However, industry analysts remain skeptical about the drug's potential to compete in the crowded eczema treatment landscape.

NoahAI News6/26/2025
Moon Surgical Expands Leadership Team to Accelerate Maestro Robot Commercialization

Moon Surgical Expands Leadership Team to Accelerate Maestro Robot Commercialization

Moon Surgical, a rising challenger in the surgical robotics market, has announced the addition of three key executives to its leadership team. This strategic move aims to support the company's ambitious plans for the commercialization of its Maestro soft tissue robot system in the United States and Europe.

NoahAI News6/26/2025
Johnson & Johnson Launches AI Surgery Fund with Nvidia and AWS

Johnson & Johnson Launches AI Surgery Fund with Nvidia and AWS

Johnson & Johnson (J&J) has unveiled a groundbreaking initiative to accelerate the integration of artificial intelligence (AI) in surgical practices. The pharmaceutical and medical device giant has partnered with tech behemoths Nvidia and Amazon Web Services (AWS) to establish the Polyphonic AI Fund for Surgery, a program designed to foster innovation in pre-operative, intra-operative, and post-operative care.

NoahAI News6/26/2025
Minovia Therapeutics Aims for Public Market via SPAC Merger

Minovia Therapeutics Aims for Public Market via SPAC Merger

Israeli biotech company Minovia Therapeutics is set to enter the public market through a merger with special purpose acquisition company (SPAC) Launch One Acquisition. The deal, announced on June 25, 2025, comes at a time when traditional initial public offerings (IPOs) remain challenging in the current economic climate.

NoahAI News6/26/2025
Rebuilding Trust and Retaining Talent: Leadership Strategies in Biopharma After Layoffs

Rebuilding Trust and Retaining Talent: Leadership Strategies in Biopharma After Layoffs

In the wake of widespread layoffs across the biopharmaceutical industry, executives are grappling with the challenge of restoring trust and retaining top talent. A recent column by Michael Pietrack, practice lead for Kaye/Bassman's pharma and biotech recruiting team, outlines five critical strategies for leaders to navigate this turbulent period.

NoahAI News6/26/2025
AI Startup Insight Health Launches Virtual Care System to Streamline Clinical Workflows

AI Startup Insight Health Launches Virtual Care System to Streamline Clinical Workflows

Insight Health, a new startup in the healthcare AI space, has emerged from stealth mode with a suite of artificial intelligence agents designed to handle routine clinical tasks. The company's technology aims to significantly reduce the administrative burden on healthcare providers while improving patient engagement and care quality.

NoahAI News6/26/2025
Arbutus Biopharma Regains China Rights to Hepatitis B Drug Imdusiran in Strategic Shift

Arbutus Biopharma Regains China Rights to Hepatitis B Drug Imdusiran in Strategic Shift

Arbutus Biopharma has announced a significant strategic move, regaining the China rights to its potential functional cure for hepatitis B, imdusiran. This development comes as part of a broader restructuring effort by the company to streamline its operations and focus on advancing its pipeline.

NoahAI News6/26/2025
Novartis Inks $750M Biobucks Deal with ProFound Therapeutics for Cardiovascular Drug Development

Novartis Inks $750M Biobucks Deal with ProFound Therapeutics for Cardiovascular Drug Development

In a significant move to bolster its cardiovascular pipeline, Swiss pharmaceutical giant Novartis has entered into a four-year collaboration with ProFound Therapeutics, a Flagship Pioneering-founded biotech company. The partnership, announced on June 26, aims to develop first-in-class medicines for a range of cardiovascular diseases, leveraging ProFound's innovative protein detection platform.

NoahAI News6/26/2025
Healthcare Finance Leaders Anticipate Challenges Amid Policy and Economic Uncertainty

Healthcare Finance Leaders Anticipate Challenges Amid Policy and Economic Uncertainty

Healthcare finance executives are bracing for potential storms on the horizon, as policy changes and economic uncertainties loom large over the industry. A recent Deloitte survey of 64 finance leaders from health systems and insurers reveals growing concerns about future business conditions and profitability.

NoahAI News6/26/2025
TIGIT Failures Cast Shadow Over Immuno-Oncology Investments

TIGIT Failures Cast Shadow Over Immuno-Oncology Investments

Major pharmaceutical companies have invested billions in TIGIT-targeted immunotherapy programs, only to face significant setbacks and financial losses. This trend highlights the ongoing challenges in developing effective cancer treatments and raises questions about the industry's approach to high-risk, high-reward drug development.

NoahAI News6/26/2025
Cosmo Pharmaceuticals to Revolutionize Colonoscopies with Apple Vision Pro Integration

Cosmo Pharmaceuticals to Revolutionize Colonoscopies with Apple Vision Pro Integration

Cosmo Pharmaceuticals is set to transform gastrointestinal procedures by combining its AI-powered GI Genius system with Apple's cutting-edge virtual reality technology. This innovative approach aims to enhance physician workflow and improve patient outcomes in colorectal cancer screening.

NoahAI News6/26/2025
«1...678...67»